2026 COMPLIANCE: OUR PORTFOLIO IS FULLY OPTIMIZED FOR PRIVATE PRACTICE AND ASC SETTINGS UNDER THE 2026 FLAT-RATE UPDATES

THE

REGENEDGE

ADVANTAGE

CORE DISTRIBUTION PORTFOLIO

AI IMAGING

Non-contact fluorescence to identify infection before a hospital readmission.

(CPT 0598T)

FISH COLLAGEN

Anhydrous Fish Collagen: High-performance, shelf-stable matrix.

(CPT A2014)

ACOUSTIC MIST

Portable, painless ultrasonic debridement mist.

(CPT 97610)

PRP GEL

Rapid autologous gel produced chairside to jumpstart chronic wounds.

(CPT G0465)

QUAD-LAYER GRAFT

Quad-Layer Functional Grafts: Full-thickness support for complex, deep granular deficits.

WEBSITE
OPTIMIZATION

Capture high-intent wound care patients already searching online by improving your visibility and SiteScore trust.

NEW FOR 2026

PRACTICE INTEGRATION

We don't just sell products; we provide a comprehensive Practice Integration model. Our team assists with seamless implementation and complex reimbursement navigation, ensuring your clinical workflow remains efficient and compliant under the 2026 flat-rate updates.

Schedule a Clinical Portfolio Review

Request Revenue Analysis

2026 COMPLIANT
FOR PRIVATE PRACTICE & ASC

Our curated portfolio of advanced regenerative technologies is fully optimized for the 2026 flat-rate updates, ensuring your practice remains at the forefront of clinical excellence and billing safety.

READY TO OPTIMIZE YOUR REVENUE?

Request a Clinical Portfolio Review or Revenue Analysis to navigate the 2026 flat-rate landscape with confidence.

"We believe that advanced regenerative technologies, when paired with clinical excellence and 2026-compliant billing, represent the pinnacle of patient healing and practice sustainability."

THE